documents: FDA-2021-D-0756-0003

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2021-D-0756-0003 FDA FDA-2021-D-0756 Requests the FDA to extend the comment period for this Guidance by 90 days (150 days in total), or until May 23, 2022 Other Electronic Regulation from Form 2022-02-17T05:00:00Z 2022 2 2022-09-01T04:00:00Z   2025-01-07T17:17:35Z   0 0 0900006484f814cf

Links from other tables